Why Accretive Health Shares Imploded

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shareholders of revenue cycle management services company Accretive Health (NYSE: AH  ) are finding themselves in need of a hospital today after their stock tumbled 28% in response to comments from Minnesota's attorney general.

So what: In late March, Accretive Health agreed to no longer collect debt on behalf of Fairview Health Services in response to this same lawsuit. Today's news widens the scope of that investigation beyond just Fairview, and the allegations made by the attorney general contend that Accretive's employees didn't properly disclose their roles to patients and that they attempted, in some cases, to collect from patients prior to them even receiving care. Further, it appears that Fairview Health's tax-exempt status may be in jeopardy because of Accretive's aggressive debt-collecting tactics.

Now what: Last month when Accretive announced the loss of the Fairview account, it shaved about 6% of its revenue off its full-year forecast. With the scope of this investigation expanding, it's quite possible the impact to Accretive's bottom line may expand as well. At some point Accretive will be worth a look, but even after today's drop, 14 times forward earnings is still too much to pay with so many questions still on the table.

Craving more input? Start by adding Accretive Health to your free and personalized watchlist so you can keep up on the latest news with the company.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 25, 2012, at 10:15 PM, propjock1 wrote:

    Should I buy or dump. Got hammered on this today??

  • Report this Comment On April 26, 2012, at 3:13 PM, grammargramma wrote:

    The subject of a gerund is always in the possessive case. Therefore, your statement should be "...prior to THEIR receiving care." A gerund is a verb form, ending in _i_ _n_ _g_, that is used as a noun, in this case, _receiving_.

    I bought a pile of Accretive this a.m.

Add your comment.

DocumentId: 1870772, ~/Articles/ArticleHandler.aspx, 4/23/2014 9:04:55 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement